### Merck & Co., Inc. (MRK)

**MRK03 – Merck & Co., Inc. (NYSE: MRK)**  Merck & Co., Inc. (MRK) is a global biopharmaceutical company focused on developing innovative medicines, vaccines and animal health solutions. Its portfolio includes KEYTRUDA, one of the company’s key oncology products, alongside vaccines and treatments across areas such as cardiometabolic and respiratory diseases. With a broad research pipeline and growing contributions from new product launches, Merck is positioned to capture long-term opportunities from continued demand for innovative healthcare solutions. The company also has a track record of returning capital to shareholders through regular dividend payments. However, its business remains exposed to clinical and regulatory risks, product competition, patent expirations and the uncertainty of pharmaceutical development.


#### Additional Details

<style>
        #table {
            width: 100%;
            border-collapse: collapse;
            font-family: Arial, sans-serif;
        }

        #table th, #table td {
            border: 1px solid #ddd;
            padding: 8px;
            text-align: left;
            color: #222; /* Darker Font */
        }

        #table th {
            background-color: #D9D9D9; /* Light Grey */
            color: #111; /* Very Dark Text for Header */
            font-weight: bold;
        }

        #table tr:nth-child(even) {
            background-color: #F4F4F4; /* Very Light Grey */
        }

        #table tr:nth-child(odd) {
            background-color: #FFFFFF; /* White */
        }

        #table a {
            color: #000; /* Black for Links */
            text-decoration: none;
            font-weight: bold;
        }

        #table a:hover {
            text-decoration: underline;
        }
</style>

<table id="table">
    <tr>
        <th>Issuer</th>
        <td>Pi Securities Public Company Limited</td>
    </tr>
    <tr>
        <th>DR Symbol</th>
        <td>MRK03 </td>
    </tr>
    <tr>
        <th>DR Reference Ratio</th>
        <td>2000 DR : 1 UL</td>
    </tr>
    <tr>
        <th>Underlying Security</th>
        <td>Merck & Co., Inc. (MRK)</td>
    </tr>
    <tr>
        <th>Type of Underlying Security</th>
        <td>Common Stock</td>
    </tr>
    <tr>
        <th>Exchange of Underlying Security</th>
        <td>U.S. Equities Exchanges</td>
    </tr>
    <tr>
        <th>Reference Asset Issuer’s Website</th>
 <td><a href="https://www.merck.com/" target="_blank">MRK Website</a></td>
    </tr>
</table>

MRK03 – Merck & Co., Inc. – Advancing Healthcare Through Innovation and Breakthrough Medicines

Merck & Co., Inc. (MRK)

Additional Details

Merck & Co., Inc. (MRK)

DR Price